Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
基本信息
- 批准号:10089447
- 负责人:
- 金额:$ 38.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAffectAgonistAmino AcidsAnteriorArginineAspartic AcidAutoimmuneAutoimmune DiseasesBiochemicalBiocompatible MaterialsBurn injuryCell CountCell ProliferationCell SurvivalCell physiologyCellsCharacteristicsChemicalsCholinergic AgonistsCicatrixConjunctival EpitheliumConjunctival PterygiumCorneaCultured CellsDepositionDevelopmentDiseaseEGF geneElectrolytesEnzyme-Linked Immunosorbent AssayEpithelialEpithelial CellsEyeEyelid structureFibroinsFilmGenetic DiseasesGlassGluesGlycineGoalsGoblet CellsGrantGrowthGrowth FactorHumanImageImmunofluorescence MicroscopyInfectionInflammationInflammatoryIonsLocationMUC5AC geneMeasurementMeasuresMechanicsMediator of activation proteinMedicineMembraneMetalsMolecularMucinsNatural regenerationNerve Growth FactorsOcular cicatricial pemphigoidOperative Surgical ProceduresPainPatientsPhenotypePhysiologicalProductionProliferatingPublishingReproducibilitySerotoninSilkSquamous CellStevens-Johnson SyndromeStimulusStressStructure of molecular layer of cerebellar cortexSurfaceSurgical suturesTechniquesTight JunctionsTissuesTitaniumTrachomaTransplantationTraumaUndifferentiatedVisual impairmentWaterbasebiomaterial compatibilitycell growthcell injurycell typeconjunctivacytokinehealinghuman femalehydrophilicityimprovedmalenovelocular surfacephysical propertypreventrelating to nervous systemrepairedresponsescaffoldsexstandard of caretitanium dioxidewater channelwoundwound closurewound healing
项目摘要
Abstract A1-R01 Grant Title: Construction of Conjunctival Equivalents Using Molecular Deposition
Techniques
A robust, functional conjunctiva with goblet, stratified squamous, and undifferentiated cells is critical for a
transparent cornea and a healthy anterior eye. Ocular surface disorders, including, infectious (trachoma),
autoimmune (ocular cicatricial pemphigoid), and genetic diseases, as well as burns and Stevens-Johnson
syndrome, can damage the ocular surface, especially the conjunctiva, by scarring. Although the conjunctiva
has substantial repair potential, these diseases are painful inflammatory diseases and the patients are
desperate for better treatments. Current treatments include use of redundant conjunctiva or amniotic
membrane. Development of novel biocompatible materials is providing improved treatments in the field of
regeneration medicine. For this proposal we will take advantage of the newly developed molecular layer
deposition (MLD) technique to build coatings of bioactive materials. Our overall goal is to develop a
transplantable and functional conjunctival construct consisting of the three types of human conjunctival
epithelial cells (undifferentiated, stratified squamous, and goblet) growing on our novel surface. The surface is
based on an MLD film deposited on a silk fibroin matrix that is easily manipulated for surgical transplantation.
For SA1 we will characterize the phenotype of conjunctival epithelial cells growing on MLD silk construct and
compare it with cells growing on amniotic membrane. For SA2 we will evaluate the function of the three types
of epithelial cells growing on our constructs of MLD silk in response to physiological stimuli of cell function and
compare them with cells growing on amniotic membrane. For SA3 we will measure the repair response to a
mechanical injury of the cells on constructs of MLD silk compared to amniotic membrane. Cell counting,
molecular, and immunofluorescence microscopy techniques will be used to evaluate amount and phenotype of
cell growth. Physical techniques will be used to determine construct strength. Ca2+ imaging, ELISAs for
MUC5AC secretion, and other physiological techniques will be used to determine function of cells on the
construct. Immunofluorescence microscopy and multi-cytokine measurements will be used to evaluate wound
healing. The final product of three types of conjunctival epithelial cells grown on MLD silk will be functional, and
transplantable and excellent for repair of the diseased and damaged conjunctiva.
摘要A1-R01赠款标题:使用分子沉积的结合等效物的构建
技术
与杯状,分层的鳞状和未分化的细胞具有强大的功能性结膜,对于A至关重要
透明的角膜和健康的前眼。眼表面疾病,包括感染性(沙眼),
自身免疫性(眼刺刺激)和遗传疾病,以及烧伤和史蒂文斯 - 约翰逊
综合征会通过疤痕损害眼表,尤其是结膜。虽然结膜
具有巨大的修复潜力,这些疾病是疼痛的炎症性疾病,患者是
迫切需要更好的治疗。当前的处理包括使用冗余结膜或羊水
膜。新型生物相容性材料的开发正在提供改进的治疗
再生医学。对于此提案,我们将利用新开发的分子层
建造生物活性材料涂层的沉积(MLD)技术。我们的总体目标是开发
可移植和功能性结合结构,由三种类型的人类结合
上皮细胞(未分化,分层的鳞状和杯状)生长在我们的新表面上。表面是
基于沉积在丝纤维蛋白基质上的MLD膜,该膜很容易被操纵以进行手术移植。
对于SA1,我们将表征生长在MLD丝构建体和的结膜上皮细胞的表型
将其与羊膜上生长的细胞进行比较。对于SA2,我们将评估三种类型的功能
响应细胞功能的生理刺激和
将它们与羊膜上生长的细胞进行比较。对于SA3,我们将测量对A的维修响应
与羊膜相比,细胞在MLD丝的构建体上的机械损伤。细胞计数,
分子和免疫荧光显微镜技术将用于评估数量和表型
细胞生长。物理技术将用于确定构造强度。 Ca2+成像,ELISA
MUC5AC分泌和其他生理技术将用于确定细胞在
构造。免疫荧光显微镜和多创代因子测量将用于评估伤口
康复。在MLD丝上生长的三种类型的结膜上皮细胞的最终产物将是功能性的,并且
可移植,非常适合修复患病和损坏的结膜。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Darlene A Dartt其他文献
Darlene A Dartt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Darlene A Dartt', 18)}}的其他基金
Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures
芥子气引起的结膜损伤的机制以及脂质介质作为医疗对策的使用
- 批准号:
10882060 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
10338062 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
10557095 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
9884619 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution
炎症中结膜杯状细胞粘蛋白的分泌及其解决
- 批准号:
9920424 - 财政年份:2019
- 资助金额:
$ 38.22万 - 项目类别:
Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial Infection
眼表细菌感染中的结膜杯状细胞NLRP3炎症小体
- 批准号:
8461558 - 财政年份:2012
- 资助金额:
$ 38.22万 - 项目类别:
Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial Infection
眼表细菌感染中的结膜杯状细胞NLRP3炎症小体
- 批准号:
8663916 - 财政年份:2012
- 资助金额:
$ 38.22万 - 项目类别:
Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial Infection
眼表细菌感染中的结膜杯状细胞NLRP3炎症小体
- 批准号:
8274619 - 财政年份:2012
- 资助金额:
$ 38.22万 - 项目类别:
Lacrimal Gland Regeneration:Identification and Isolation of Progenitor Cells
泪腺再生:祖细胞的鉴定和分离
- 批准号:
7978066 - 财政年份:2010
- 资助金额:
$ 38.22万 - 项目类别:
Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution
炎症中结膜杯状细胞粘蛋白的分泌及其解决
- 批准号:
8990960 - 财政年份:2009
- 资助金额:
$ 38.22万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:82101697
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Enteric Glia as a Possible Target for Symptom Relief in Endometriosis
肠胶质细胞作为缓解子宫内膜异位症症状的可能目标
- 批准号:
10625609 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Probing Mechanisms of Polycystin-1 Regulation Using Peptide Modulators Designed by Sequence- and Structure-Based Learning
使用基于序列和结构的学习设计的肽调制器探索多囊蛋白-1 调节机制
- 批准号:
10917464 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
The Role of Layilin as a Novel Regulator of Platelet Activation and Thromboinflammation
Layilin 作为血小板活化和血栓炎症的新型调节剂的作用
- 批准号:
10638243 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Targeting the Thromboinflammatory Response to Mitigate Bowel Injury in Necrotizing Enterocolitis
靶向血栓炎症反应以减轻坏死性小肠结肠炎的肠道损伤
- 批准号:
10840235 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别:
Investigating the Effects of ADGRB3 Signaling on Incretin-Mediated Insulin Secretion from Pancreatic Beta-Cells
研究 ADGRB3 信号传导对肠促胰素介导的胰腺 β 细胞胰岛素分泌的影响
- 批准号:
10666206 - 财政年份:2023
- 资助金额:
$ 38.22万 - 项目类别: